Company Overview

Business Description

Sector
Health Care
Industry
Health Care
Headquarters
Canada CA
IPO date
Jul 11, 2001

Therma Bright, Inc. engages in developing and marketing skin care medical device products. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.

Therma Bright Inc Investor Relations

Address
1173 Dundas Street East, Suite 132
Toronto, Ontario
Canada

Management

Mr. Roberto Fia C.F.A.

Chairman, President & CEO

Biography unavailable

Mr. Michael Mayo

Director of Sales

Biography unavailable

1 / 2